Publications by authors named "Rizvan Bush"

Claim this Profile
A
A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.
Marco A Salvino, Flavio A V Luisi, Mara A Pianovski, Franca Fagioli, Sidnei Epelman, Rizvan Bush

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group.
Ilia N Buhtoiarov, Nkechi I Mba, Crystal D L Santos, Kathleen M McCarten, Monika L Metzger, Rizvan Bush

Pediatr Blood Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu

Blood· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.
Justine M Kahn, Kara M Kelly, Qinglin Pei, Rizvan Bush, Debra L Friedman

J Clin Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.
Kara M Kelly, Peter D Cole, Qinglin Pei, Rizvan Bush, Kenneth B Roberts

Br J Haematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
Lianna J Marks, Qinglin Pei, Rizvan Bush, Allen Buxton, Burton Appel

Pediatr Blood Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.
Peter D Cole, Kathleen M McCarten, Qinglin Pei, Menachem Spira, Monika L Metzger, Rizvan Bush

Lancet Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
Frank G Keller, Sharon M Castellino, Lu Chen, Qinglin Pei, Stephan D Voss, Rizvan Bush

Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
Aaron Parzuchowski, Rizvan Bush, Qinglin Pei, Debra L Friedman, Thomas J FitzGerald

Int J Radiat Oncol Biol Phys· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis